1. Home
  2. NRXS vs BCIC Comparison

NRXS vs BCIC Comparison

Compare NRXS & BCIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neuraxis Inc.

NRXS

Neuraxis Inc.

HOLD

Current Price

$4.44

Market Cap

76.9M

Sector

N/A

ML Signal

HOLD

BCIC

BCP Investment Corporation

HOLD

Current Price

$5.11

Market Cap

74.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRXS
BCIC
Founded
2011
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
76.9M
74.1M
IPO Year
2023
2006

Fundamental Metrics

Financial Performance
Metric
NRXS
BCIC
Price
$4.44
$5.11
Analyst Decision
Strong Buy
Hold
Analyst Count
2
4
Target Price
★ $11.00
$8.50
AVG Volume (30 Days)
★ 146.5K
82.0K
Earning Date
11-09-2026
11-11-2026
Dividend Yield
N/A
★ 21.05%
EPS Growth
22.13
★ 262.50
EPS
★ N/A
N/A
Revenue
★ $3,569,282.00
N/A
Revenue This Year
$118.53
N/A
Revenue Next Year
$101.28
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 32.89
N/A
52 Week Low
$2.50
$4.99
52 Week High
$9.33
$13.44

Technical Indicators

Market Signals
Indicator
NRXS
BCIC
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
NRXS
BCIC

About NRXS Neuraxis Inc.

Neuraxis Inc is a growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in the gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).

About BCIC BCP Investment Corporation

BCP Investment Corp is an externally managed, non-diversified closed-end investment company. The company invests in secured term loans, bonds or notes and mezzanine debt in privately-held middle market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation from the investments in senior secured term loans, mezzanine debt and selected equity investments in privately-held middle market companies.

Share on Social Networks: